FLETCHER R JOHN 4

What Happened
Fletcher R. John, a director of ClearPoint Neuro, received an award of 1,270 shares of ClearPoint common stock on April 1, 2026. The shares were issued at $9.10 each (the closing price on March 31, 2026), for a total value of $11,557. This transaction is coded as an award/grant (A) — a payment of fees, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Filing date: 2026-04-02 (timely; insiders typically must file within 2 business days).
• Price per share: $9.10; Total value: $11,557.
• Transaction type/code: Award/Grant (A) — issued as compensation.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Shares were issued under the issuer’s Sixth Amended and Restated 2013 Incentive Compensation Plan as payment for fees owed under the Non-Employee Director Compensation Plan, issued at the March 31, 2026 closing price.

Context
This was a director compensation award (stock issued in lieu of cash fees), which is a routine corporate practice and does not necessarily signal the director’s view of the stock. For investors tracking insider activity, purchases or open-market buys tend to carry more interpretive weight than compensatory awards.